The emergence of AI in drug discovery is shifting from merely having models to developing integrated scientific workflows that deliver tangible results.
At BIO USA 2026, NVIDIA emphasized that the future of AI in drug discovery hinges on its ability to perform genuine scientific tasks rather than just showcasing advanced models. This message was underscored by Anthropic's recent launch of Claude Science, an AI workbench that enables scientists to manage research tasks and analyze data using natural language within a cohesive environment. This tool exemplifies a broader shift in life sciences, where the focus is moving toward establishing effective systems that leverage AI to facilitate scientific processes.
Korean biotech and pharmaceutical firms have been vocal about their AI initiatives in drug discovery and clinical development. However, NVIDIA's insights indicate that investors and collaborators are now more interested in whether these companies can create functional workflows that integrate data, tools, and human expertise. The BioNeMo Agent Toolkit, introduced at the conference, aims to provide domain-specific tools that allow AI agents to conduct experiments and derive actionable insights, marking a departure from viewing AI merely as a predictive tool.
This transition presents both opportunities and challenges for Korea. While the country possesses many elements needed for a robust AI-bio ecosystem—such as advanced research institutions, skilled personnel, and governmental support—there remains a disconnect in how these components interact. To truly harness AI's potential, Korean companies must focus on creating interconnected workflows that enhance decision-making and streamline research processes. This approach will be crucial for attracting global partnerships and ensuring that AI contributes meaningfully to scientific advancements.
As the landscape evolves, the emphasis will shift from individual capabilities to the overall research system. Korean companies need to adapt by fostering collaborative environments that leverage AI to improve scientific outcomes, thereby solidifying their competitive edge on the global stage.